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Summary Squamous cell carcinoma (SCC) of the bronchus is considered to develop from preneoplastic 'dysplasia', but reports of sequential
observation of this dysplasia-carcinoma sequence in humans are very few. We followed four dysplastic lesions found in the bronchi of three
ex-chromate workers by bronchoscopy and biopsy and found that all of them progressed to SCC. Of the four lesions, three were severe
dysplasias at the first biopsy which progressed to SCCs in 7-13 months. The last one was a slight dysplasia at the first biopsy and showed
progression of the atypia to carcinoma in 6 years and 10 months. An immunohistochemical analysis of the chronological change in p53
protein expression in these lesions and in normal ciliated epithelium taken from the surroundings was conducted in each case.
Overexpression of p53 protein was observed in two of the severe dysplasias and the one slight dysplasia, as well as their eventual SCCs.
However, no such change was apparent in one case of severe dysplasia or its eventual SCC. Normal epithelium was consistently negative.
Our results provide direct proof of the dysplasia-carcinoma sequence and suggest that alteration in the expression of p53 protein might be an
important early event which persists. Therefore, the immunohistochemical detection of p53 overexpression in biopsy specimens of bronchial
epithelium might be useful for evaluation of preneoplastic lesions in high-risk group individuals and for early diagnosis of bronchial cancer.
Keywords: tumour-suppressor gene p53; immunohistochemistry; lung cancer; chromate workers; tumour progression
Dysplasia ofthe bronchial epithelium is considered to be a preneo-
plastic change that may evolve into carcinoma in situ and invasive
SCC (Sozzi et al, 1992; Sundaresan et al, 1992; ; Bennet et al,
1993; Nuorva et al, 1993). However, most studies of the
dysplasia-carcinoma sequence have concentrated on histological
examination or genetic and/or chromosomal abnormalities in the
bronchial epithelia of post-mortem or post-operative lung cancer
patients, and follow-up studies in vivo have been limited
(Thiberville et al, 1995). While a great deal of information points
to an important role of p53 mutations in the development of
bronchial carcinomas and gene alteration may occur in preneo-
plastic lesions (Vogelstein, 1990; Sozzi et al, 1992; Klein et al,
1993), there has been no report of a dysplasia with p53 abnor-
mality progressing sequentially to a carcinoma. The rarity of
follow-up studies ofthe dysplasia-carcinoma sequence and ofp53
abnormalities is related to the difficulty of finding preneoplastic
lesions in the bronchi, because of their small size, location and
difficulties in sampling.
Chromate workers are known to be a high-risk group for devel-
oping preneoplastic lesions and/or lung cancers and provide a
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good model for bronchial carcinogenesis (Pfeil, 1935; Baetjer,
1950; Hueper, 1966). We have been following bronchial epithelial
changes in ex-chromate workers using sputum cytology, broncho-
scope and biopsy and have found several dysplastic lesions, some
ofwhich were considered likely to progress to SCCs (Nakagawa et
al, 1984; Ishikawa et al, 1994).
In this paper, we document the histological change from
dysplasias to carcinomas over various periods and the results of
immunohistochemical examination ofp53 protein expression.
MATERIALS AND METHODS
Subjects
Since October 1975, we have followed up a population of 84 men
employed in a Tokyo factory that produced chromate compounds
until August 1975. All ofthe 84 ex-workers underwent chest radi-
ography and sputum cytology examinations in a local hospital
every 6-12 months. On detection of abnormal radiological
shadows, or atypical cells on sputum cytology, patients were
admitted to our hospital. Further examinations, such as bron-
choscopy with biopsy and computerized tomography (available
since 1980), were then performed. In subjects with cancer, appro-
priate therapies including surgical intervention, irradiation and
chemotherapy were applied. When premalignant bronchial lesions
were found, re-examination by bronchoscopy with biopsy was
performed regularly thereafter. Four lesions in three cases were
found which progressed to SCC. When they were first found, the




Figure 1 Severe dysplasia in the lesion B case. (A) Haematoxylin and eosin
staining. (B) Positive immunostaining with p53
Figure 2 Severe dysplasia in the lesion C case. (A) Haematoxylin and eosin
staining. (B) Positive immunostaining with p53
Table 1 Histories of exposure to chromate and cigarette smoke for the ex-chromate workers (male) examined
Case Age Duration of exposure to Latencya
no. (years) chromate (years) (years)
Exposure to cigarette smoke
(smoking indexb)
1 65 23.8 43.7 980
2 63 22.5 37.1 780
3 71 24.6 33.2 370
aPeriod from start of exposure to diagnosis of the first carcinoma. bA product of the numbers of cigarettes per day and the duration of smoking in years.
Table 2 Histological changes in preneoplastic bronchial lesions
Case Subject Degree of atypia
no.
First biopsy Following biopsies
1 Lesion A (year/month) 82/2 82/5 82/9
Severe dysa* Severe dysa SCCb*
Lesion B (year/month) 88/3 88/11
Severe dysa* SCCb*
2 Lesion C (year/month) 82/10 82/11 83/11
Severe dysa* Sqmc SCCb*
3 Lesion D (year/month) 83/1 85/3 85/8 85/12 86/4 86/9 87/1 87/5 87/11 88/5 89/1
Slight dysa* Moderate dysa Moderate dysa Severe dysa Sqmc Slight dysa Slight dySa Cilid _e Cilid SCCa*
aDysplasia. bSquamous cell carcinoma. cSquamous metaplasia without atypia. dCiliated bronchial epithelium. elnsufficient material. *Material examined for p53
protein overexpression immunohistochemically.
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Figure 3 Squamous metaplasia without atypia in the lesion C case
(haematoxylin and eosin staining)
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four lesions were located at the bifurcation, less than 5 mm in
diameter, and the mucosa in all cases was red and oedematous with
a smooth or granular appearance. These lesions were examined for
expression ofp53 protein immunohistochemically.
Tissue samples
In each case, biopsy specimens were obtained from the dysplasias,
the carcinomas and the normal bronchial epithelium adjacent to
the lesion. All of the specimens were fixed in buffered formalin,
embedded in paraffin and serially sectioned at 4 gm. One section
of each sample was stained with haematoxylin and eosin, and
histological diagnosis was made according to the WHO classifica-
tion (1981). Dysplasia was divided into three grades (slight,
moderate and severe) according to the degree ofcellular and struc-
tural atypia. This grading is similar to that used for cervical
dysplasias (WHO, 1975). The other serial section was prepared for
the immunohistochemical demonstration ofp53 using the anti-p53
rabbit polyclonal antibody, RSP53 (Nichirei, Tokyo, Japan), that
binds to both mutant and wild-type proteins. For the immunos-
taining, a kit for the streptavidin-biotin method was applied
following the manufacturer's instructions (Histofine SAB-PO(M)
Kit, Nichirei). The p53 reactivities were evaluated quantitatively
and divided into two groups (-, negative; +, more than 1% of the
cells positive) according to the estimated number ofpositive nuclei
ofeither dysplastic or carcinoma cells.
Exposure to chromate compounds and cigarette smoke
The histories of exposure to chromate compounds, latent periods
and smoking histories for the three cases are given in Table 1.
More details of chromium contents in the lungs of ex-chromate
workers were described in an earlier paper (Ishikawa et al, 1994).
RESULTS
Progressive changes in preneoplastic lesions observed
during follow-up
Details of histological changes occurring in the four preneoplastic
bronchial lesions in the three cases are summarized in Table 2. For
lesion A of case 1, the first biopsy specimen was taken from a
bifurcation of the second bronchus in the left upper lobe.
B
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Figure 4 Slight dysplasia in lesion D at the first biopsy. (A) Haematoxylin
and eosin staining. (B) Positive immunostaining with p53)
Microscopically, severe dysplasia was diagnosed. The second
biopsy ofthe lesion, 3 months after the first, again revealed severe
dysplasia. The last biopsy, 4 months after the second, SCC was
found. The duration from the first diagnosis of dysplasia to the
carcinoma appearance was 7 months. For lesion B of case 1, the
tissue at the first biopsy was taken from a bifurcation ofthe second
bronchus in the left lower lobe. Microscopically, severe dysplasia
was evident (Figure IA). The second biopsy, taken after 8 months,
showed SCC. For lesion C in case 2, the first biopsy specimen,
taken from the second carina of the left lung, demonstrated severe
dysplasia (Figure 2A). Although a second biopsy 1 month after the
first showed squamous metaplasia without atypia (Figure 3), a
third biopsy performed 1 year later demonstrated SCC, the total
duration being 13 months. Lesion D in case 3, located at the third
bronchus of right lower lobe, was diagnosed as slight dysplasia at
the first biopsy (Figure 4A). A second biopsy, 2 years and 2
months after the first, showed moderate dysplasia (Figure 5A).
Subsequent follow-up histological examinations by biopsy
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Figure 5 Subsequent follow-up biopsies after the second biopsy in the lesion D case (haematoxylin and eosin staining). (A) Moderate dysplasia (March, 1985): (B) severe dysplasia (December, 1985): (C) slight dysplasia (January, 1987): (D) ciliated bronchial epithelium (May, 1988)
Table 3 Results of p53 immunohistochemical staining for the biopsy specimens of bronchial lesions in the three cases
Case Subject First biopsy specimens Squamous cell Ciliated normal Duration between the appearance of the preneoplastic
no. (degree of atypia) carcinoma bronchial mucosa lesion and the squamous cell carcinoma
1 Lesion A - (Severe dysplasia) - - 7 months
Lesion B + (Severe dysplasia) + - 8 months
2 Lesion C + (Severe dysplasia) + - 13 months
3 Lesion D + (Slight dysplasia) + - 6 years and 10 months
-, negative reaction for p53; +, positive reaction for p53.
demonstrated moderate dysplasia, severe dysplasia (Figure 5B),
squamous metaplasia, slight dysplasia, slight dysplasia (Figure
5C), ciliated bronchial epithelium (Figure 5D) and finally SCC
(Figure 6). The duration from the first biopsy to carcinoma was 6
years and 10 months (Table 3).
As none of the four carcinomas were surgically resected, their
precise sizes could not be determined. However, from endoscopic
findings, they were all less than 10 mm in diameter.
Immunohistochemical staining
The first biopsy specimen ofeach lesion and the related carcinoma
and the ciliated normal bronchial epithelium were available for
examination of p53 immunostaining. As shown in Table 3, p53
overexpression was detected in three offour dysplasias and in the
related SCCs (Figures lB, 2B, 4B and 6B). The average percent-
ages of positive nuclei in dysplastic and tumour cells were
as follows: 30% for slight dysplasia, more than 50% for
severe dysplasia and 90% for SCC. In lesion A, however, both of
the severe dysplasia and the related SCC showed negative
staining. The ciliated normal bronchial epithelium in each case did
not stain.
DISCUSSION
The first follow-up study of the dysplasia-carcinoma sequence
was performed by Saccomanno et al (1974), who examined
sequential sputum cytology specimens of uranium miners and
confirmed the presence of a sequence in many cases. No subse-
quent reports appeared until Ishikawa et al (1994) described bron-
choscopy and biopsy findings for one lesion which progressed
from severe dysplasia to carcinoma in the same population as
examined here. The present four lesions confirm and extend the
previous findings using the same observation methods.
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Abnormalities ofthep53 gene can be examined at the molecular
level for invasive carcinomas of the lung, but with preneoplastic
lesions the immunohistochemical approach is easier to apply
(Sozzi et al, 1992; Sundaresan et al, 1992). Nuorva et al (1993)
examined p53 expression in preneoplastic bronchial lesions with
various degrees of atypia and found that accumulation of p53
protein started at the stage of moderate or severe dysplasia. On
the other hand, Bennett et al (1993) reported 6.7% and 29.5%
p53 overexpression, even in squamous metaplasias and slight
dysplasias respectively. Our study also revealed positive staining
in one case with slight dysplasia. Therefore, p53 protein accumula-
tion can be considered to be a very early event.
Until the present report, however, there has been no direct
evidence that preneoplastic lesions with p53 overexpression can
progress to p53-positive carcinomas. Therefore, our immunohisto-
chemical finding ofp53 overexpression in premalignant and asso-
ciated malignant lesions of the bronchial mucosa is of particular
interest, confirming a role for irreversible change in this tumor-
suppressor gene (Greenblatt et al, 1994). It provides further
support for the conclusion of a dysplasia-carcinoma sequence in
the development of squamous cell carcinomas in ex-chromate
workers.
Lesions like squamous metaplasia or slight dysplasia of the
bronchial epithelium are not infrequent, and many are reversible in
nature (Tipton and Crocker, 1964); therefore, it is not practical to
follow up all ofthem endoscopically. However, as indicated by the
analysis of lesion D which had slight dysplasia and showed p53
overexpression, immunohistochemical assessment of this para-
meter in samples of slight dysplasia or squamous metaplasia
obtained by biopsy may be a useful means to evaluate the likeli-
hood of progression to a carcinoma. Those lesions showing p53
protein overexpression in more than 30% of the constituent cells
are likely to possess ap53 gene mutation and to be irreversible, as
indicated above.
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